FunPep

Notice of participation in “Biotech Showcase 2023”

We are pleased to announce that we will participate in “Biotech Showcase 2023” for partnering to co-develop antibody-inducing peptides*.

Biotech Showcase 2023 will be held in San Francisco at the same time as the JP Morgan Healthcare Conference, the largest investor symposium in the healthcare industry.

* https://www.funpep.co.jp/en/antibody-inducing-peptide

Date:　 January 9–11, 2023

Location： The Hilton San Francisco Union Square in San Francisco, CA

Biotech Showcase 2023

https://informaconnect.com/biotech-showcase/

Announcement of Preliminary Results for the Phase III Clinical Trial of Functional Peptide SR-0379

Notice of Business Transfer to Consolidated Subsidiary

Notice of participation in “the 2022 NEDO Silicon Valley Pitch Night”

We are pleased to announce that we will participate in “the 2022 NEDO Silicon Valley Pitch Night”.

Date and time:　Thursday, September 22, 2022 at 5:30-9:00 PM (PDT)
Location： SRI International, 333 Ravenswood Avenue, Menlo Park, CA 94025

NEDO Silicon Valley Pitch Night
https://www.eventbrite.com/e/nedo-silicon-valley-pitch-night-tickets-396747541577

Exercise of Option by MEDIPAL HOLDINGS CORPORATION

Notice of Completion of Subject Enrollment in Phase III Clinical Trial of Functional Peptide SR-0379

Notice Concerning the Completion of Subject Enrollment for the Phase I/IIa Clinical Study of Antibody-Inducing Peptide FPP003

Announcement of the start of joint research with Kumamoto University

Notice of Agreement between FunPep and EPS Innovative Medicine on Collaboration in China Business